Changes

'''Genentech, Inc.''' is financially a [[pharmaceutical]] company and one of the world's most financially successful and [[biotechnology]] corporations. The company Genentech has three drugs that are billion-dollar sellers: Rituxan, for non-Hodgkin's lymphoma; [[Avastin]], for colorectal and , non-small cell lung cancers, and treats macular degeneration; and [[Herceptin ]] for breast cancer. It also has manufactures the lung cancer drug Tarceva. Big Major customers for its drugs are [[AmerisourceBergen]], [[Cardinal Health]], and [[McKesson]]. Genentech which is based in South San Francisco, California, U.S., is 56% owned by The Swiss drug company [[Roche]], which previously owned a majority of stock in the San Francisco based firm, took full ownership in 2009.<ref name="Hoovers">[http://www.hoovers.com/genentech/--ID__10628--/free-co-factsheet.xhtml Company Description: Genentech Profile], ''Hoovers'', accessed December 2009</ref> According to its website, the company is "considered the founder of the biotechnology industry." <ref>[http://www.gene.com/gene/about/index.html About Us: Leading the Biotechnology Industry], Genentech, accessed July 2007.</ref>

In 2006the fiscal year ending in December of 2008, Genentech had sales were US$9.3 billion with profits of US$2 13.1 4 billiondollars and had 11,174 employees.<ref name=">[http://www.hoovers.com/genentech/--ID__10628--/free-co-factsheet.xhtml Company Description: Genentech], Hoovers" , accessed December 2009</ref>

==From its websiteTies to the American Legislative Exchange Council=="Considered '''Genentech''' has been a corporate funder of the [[American Legislative Exchange Council]] (ALEC)<ref>American Legislative Exchange Council, [http://legacy.library.ucsf.edu/tid/xac25b00/pdf Keeping the founder Promise: Making Health Care Accessible and Affordable for All Americans], January 1993, archived in Legacy Tobacco Documents Library, accessed July 2011</ref><ref>Clearinghouse on Environmental Advocacy and Research, project of the biotechnology industryEnvironmental Working Group, Genentech has been delivering [http://web.archive.org/web/200012021600/http://wyl.ewg.org/FoxProCGI.acgi$run_module?data_code=CLEAR&extra_code=group_code=ORG197&the_type=Group& Information on the promise of biotechnology American Legislative Exchange Council], archived organizational profile, archived by Wayback Machine December 2, 2000, accessed August 19, 2011</ref>. See [[ALEC Corporations]] for more than 30 years, using human genetic information . {{about_ALEC}}==Dollars for Docs==Genentech has paid $388 million to discover1, develop888 doctors, commercialize and manufacture biotherapeutics that address significant unmet medical needs." according to ProPublica's Dollars for Docs<ref>[http://www.genehoovers.com/genegenentech/about--ID__10628--/indexfree-co-factsheet.html Corporate Overviewxhtml Has Your Doctor Received Drug Company Money? - Genentech], GenentechDollars for Docs, accessed July 27, 2007.April 2016</ref>, including to industry consultant Dr. Peter Bach.[[https://www.sourcewatch.org/index.php/Dr._Peter_Bach#cite_note-4]]

*Genentech===Facility information, Inc., San Francisco, California <ref>Humane Society progress reports & USDA-APHIS reports===For links to copies of the a facility's [[U.S. Department of Agriculture]] (USDA)-Animal Plant Health Inspection (APHIS) reports, other information and links, see also [http://www.hsusall-creatures.org/animals_in_researchsaen/general_information_on_animal_research/research_facilities/genentechres-incfr.html Stop Animal Experimentation NOW!: Facility Reports and Information]. This site contains listings for all 50 states, links to biomedical research facilities in that state and PDF copies of government documents where facilities must report their animal usage. (Search: Genentech, Inc., San Francisco, California.)  ===USDA AWA reports===As of May 26, 2009, the USDA began posting all inspection reports for animal breeders, dealers, exhibitors, handlers, research facilities and animal carriers by state. See also [http://www.aphis.usda.gov/animal_welfare/inspection_list.shtml USDA Animal Welfare Inspection Reports]. ==Clinical trials==  ===Toxic drug trials on foster children===See also [[foster child drug trials]]. ==Selected staff & board== * [[Arthur Levinson]] - Chairman * [[Ian Clark]] - CEO * [[Steve Krognes]] - CFO <ref>[http://www.hoovers.com/genentech/--ID__10628--/free-co-factsheet.xhtml Company Description: Genentech], Research FacilitiesHoovers, accessed May 2009March 2010</ref>* [[Laura A. Leber]]* [[Amo Houghton]]

For links to copies of this facility's ===Former staff===* [[UJ.S. Department of AgricultureRichard Munro]] reports indicating species, number of animals used and other information visit - CEO <ref>[http://www.all-creaturespointsoflight.org/saenabout/res-frdirectors.html Stop Animal Experimentation Now Facility Reports and Informationcfm Board of Directors], [[Points of Light Foundation]], Uaccessed July 2007</ref>* [[William D.SYoung]] - COO <ref>[http://www. Department of Agriculture-Animal Plant Health Inspection reportsbiogenidec. This Web com/site lists each /030.html Board of the 50 states; each state's name links to biomedical research facilities in that stateDirectors], [[Biogen Idec]], and to PDF copies of government documents where the facilities must report their animal usage.accessed July 2007</ref>

===Board===* [[Herbert W. Boyer]], PhD, Vice-Chairman of the Board - [[Allergan]], Inc.* [[William M. Burns]]* [[Erich Hunziker]]* [[Jonathan K.C. Knowles]], PhD* [[Arthur D. Levinson]], PhD - Board - [[Apple Computer]], Inc.* [[Debra L. Reed]] - Board - [[Halliburton Company]]* [[Charles A. Sanders]], MD <ref>[http://www.gene.com/gene/about/management/board_of_directors.html Board of Directors], Genentech, accessed July 2007</ref> ==Executive compensation (2007)== * [[Arthur D. Levinson]], Chairman, CEO - $17,124,025 (also exercised $66,268,100 in options)<ref>[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=938049 Arthur D Levinson], ''Forbes'', accessed December 2007.</ref>* [[Susan D. Desmond-Hellmann]], Divisional President - $7,820,142 (also exercised $33,465,041 in options)<ref>[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=935873 Susan D Desmond-Hellmann], ''Forbes'', accessed December 2007.</ref>* [[David A. Ebersman]] - CEO - $4,030,747<ref>[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=880695 David A Ebersman], ''Forbes'', accessed December 2007.</ref>* [[Stephen G. Juelsgaard]] - Executive VP - $4,896,340 (also exercised $24,980,534 in options)<ref>[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=899284 Stephen G Juelsgaard], ''Forbes'', accessed December 2007.</ref>* [[Richard H. Scheller]], Divisional Executive VP - $4,992,779 (also exercised $10,880,395 in options)<ref>[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=929696 Richard H Scheller], ''Forbes'', accessed December 2007</ref> ==Political contributionsContributions== Genentech gave almost $201400,500 000 to federal candidates in the 2006 2008 election cycle through its [[political action committee]] (PAC).<ref>[http://www.campaignmoney.com/political/committees/genentech-inc-political-action-committee-genenpac.asp?cycle=08 Genentech, Inc. Political Action Committee], CampaignMoney.com, accessed March 2010</ref> This is almost twice as much as in 2006, when it donated $201,500 to federal candidates. - 38% to [[Democrats]] and 57% to [[Republican Party (USA)|Republicans]].<ref>[http://www.opensecrets.org/pacs/lookup2.asp?strid=C00199257&cycle=2006 2006 PAC Summary Data], ''Open Secrets'', accessed December 2007.</ref>

=== Key executives and 2006 pay===*[[Arthur D. Levinson]], Chairman and Chief Executive Officer, $17,124,025 Genetech's lobbying made the news after its talking points showed up in the statements submitted by several members of Congress to the Congressional Record (also exercised $66the official journal of congressional proceedings),268,100 in options)during the 2009 health care reform debate. <ref>Robert Pear [http://www.forbesnytimes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=938049 Arthur D Levinson], ''Forbes'', accessed December 2007.</ref>*[[Susan D. Desmond-Hellmann]], Divisional President, $7,820,142 (also exercised $33,465,041 in options)<ref>[http:/2009/www.forbes.com11/finance15/mktguideappsus/personinfopolitics/FromPersonIdPersonTearsheet15health.jhtmlhtml?passedPersonIdpagewanted=2&_r=1&adxnnl=935873 Susan D Desmond-Hellmann], ''Forbes'', accessed December 2007.</1&ref>*[[David A. Ebersman]], Chief Financial Officer, $4,030,747<ref>[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=880695 David A Ebersman], ''Forbes'', accessed December 2007.<politics&adxnnlx=1258294232-7WmWloVRzvQfa4/ref>*[[Stephen G. Juelsgaard]], Executive Vice President, $4,896,340 (also exercised $24As1ohkQ In House,980,534 in options)<ref>[httpMany Spoke with One Voice://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=899284 Stephen G JuelsgaardLobbyists], ''Forbes'', accessed December 2007.</ref>*[[Richard H. SchellerNew York Times]], Divisional Executive Vice President, $4,992,779 (also exercised $10,880,395 in options)<ref>[http://www.forbes.com/finance/mktguideapps/personinfo/FromPersonIdPersonTearsheet.jhtml?passedPersonId=929696 Richard H Scheller], ''Forbes'', accessed December 2007November 2009</ref>

==Contact=Selected staff===*[[Laura A. Leber]]*[[J. Richard Munro]] - Retired Chairman of the Board <ref>Points of Light Foundation, [http://www.pointsoflight.org/about/directors.cfm Board of Directors], accessed July 2007</ref>*[[William D. Young]] - Former Chief Operating Officer <ref>BiogenIDEC[http://www.biogenidec.com/site/030.html Board of Directors], , accessed July 2007</ref>*[[Amo Houghton]]

=== Board of Directors===*[[Herbert W. Boyer]], Ph.D., Also Vice-Chairman of the Board of Directors of [[Allergan]], Inc.*[[William M. Burns]]*[[Erich Hunziker]]*[[Jonathan K.C. Knowles]], Ph.D.*[[Arthur D. Levinson]], Ph.D., Also member of the Board of Directors of [[Apple Computer]], Inc.*[[Debra L. Reed]], Also on the Board of Directors of [[Halliburton Company]]*[[Charles A. Sanders]], M.D.<ref>Genentech, Inc. [http://www.gene.com/gene/about/management/board_of_directors.html Board of Directors], accessed July 2007</ref> ==Contact details==

Webaddress: http://www.gene.com

* [[AIDS industry]]* [[Animal testing]]*[[Biotechnology]]* [[Foster child drug trials]]* [[HIV/AIDS]]*[[Pharmaceutical industry]]*[[Animal testingRoche]]*[[Medical Industrial ComplexStephen Evans-Freke]]- former lead investment banker*[[War on Cancer]]*[[Stacy Feld]]*[[Ralph Snyderman]]*[[Sir John Bell]]*[[Pascal Soriot]] - former CEO

[[categoryCategory:Global corporations]] [[Category:HealthPharmaceutical industry]][[Category:Pharmaceutical industryInternational]][[categoryCategory:United StatesAnimal testing]] [[Category: Animal testingBiotechnology]] [[Category: Cancer]][[Category:AIDS]][[Category:Human rights abuses]][[Category:ALEC Exposed]]